日本語 
Emeraid Inc., a healthcare AI DX startup originating from the University of Tokyo, has completed a clinical data analysis project conducted in collaboration with Integrity Healthcare Inc.
The joint initiative, which began in December 2024, focused on applying AI driven digital transformation and bioinformatics expertise within the pharmaceutical sector. Emeraid brings advanced technologies, including AI based analytics, aimed at optimizing and improving the sustainability of the medical and healthcare industry.
As part of the collaboration, the two companies worked on clinical data analysis to support pharmaceutical applications. The analysis phase has now been successfully completed.
Also Read: B-MAP and Ignis Explore Medical-Skynet AI for Clinics
This marks a concrete outcome from their partnership, demonstrating how AI DX capabilities and domain specific bioinformatics knowledge can be applied in real world pharmaceutical projects.
English